Watch HBIO. Know when insiders buy.
One email the day a filing lands. Free.
HBIO
HARVARD BIOSCIENCE INC
7.97
−0.03 −0.38%
USD · close Sep 16
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $36.3MP/E —DIV YIELD —FCF YIELD -3.08%REV TTM $87.8M −1.1%NET INCOME −$10.4MNET DEBT $30.2M52W 3.80 – 8.20SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $22.7M | +11.1% | 55.6% | −$978K | −$2.9M | — | -0.64 | $325K | $688K | −$363K | Aug 11 |
| Q1 2026 · Mar 31 | $20.8M | −4.7% | 59.0% | −$1.2M | −$3.4M | — | -0.77 | −$662K | $426K | −$1.1M | May 12 |
| Q4 2025 · Dec 31derived | $23.7M | −3.3% | 59.7% | $1.7M | −$2.8M | −15916.7% | -0.06 | −$96K | $449K | −$545K | Mar 13 |
| Q3 2025 · Sep 30 | $20.6M | −6.3% | 58.4% | $197K | −$1.2M | — | -0.03 | $1.1M | $207K | $877K | Nov 6 |
| Q2 2025 · Jun 30 | $20.4M | −11.5% | 56.4% | −$819K | −$2.3M | — | -0.52 | $2.8M | $89K | $2.7M | Aug 11 |
| Q1 2025 · Mar 31 | $21.8M | −11.2% | 56.0% | −$49.7M | −$50.3M | — | -11.42 | $3M | $513K | $2.5M | May 12 |
| Q4 2024 · Dec 31derived | $24.6M | −12.8% | 57.1% | $11K | $18K | — | 0.01 | $1.7M | $301K | $1.4M | Mar 13 |
| Q3 2024 · Sep 30 | $22M | −13.4% | 58.1% | −$1.9M | −$4.8M | — | -0.11 | −$842K | $880K | −$1.7M | Nov 6 |
| Q2 2024 · Jun 30 | $23.1M | — | 57.2% | −$2.1M | −$2.9M | — | -0.07 | −$846K | $818K | −$1.7M | Aug 11 |
| Q1 2024 · Mar 31 | $24.5M | — | 60.3% | −$2.3M | −$4.7M | — | -0.11 | $1.4M | $645K | $758K | May 12 |
| Q4 2023 · Dec 31derived | $28.2M | — | 58.0% | $282K | −$1.8M | — | -0.04 | $4.3M | $830K | $3.5M | Mar 14 |
| Q3 2023 · Sep 30 | $25.4M | — | 58.1% | −$933K | −$1.2M | — | -0.03 | $4.4M | $217K | $4.1M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $86.5M | 57.7% | −$48.6M | −$56.7M | -65.5% | -1.28 | $6.7M | $1.3M | $5.5M | — | — |
| FY2024 · to Dec 31 | $94.1M | 58.2% | −$6.2M | −$12.4M | -13.2% | -0.28 | $1.4M | $2.6M | −$1.2M | — | — |
| FY2023 · to Dec 31 | $112.3M | 58.9% | $1.9M | −$3.4M | -3.0% | -0.08 | $14M | $1.8M | $12.2M | — | — |
| FY2022 · to Dec 31 | $113.3M | 53.7% | −$6.9M | −$9.5M | -8.4% | -0.23 | $1.2M | $1.6M | −$438K | — | — |
| FY2021 · to Dec 31 | $118.9M | 56.9% | $2.1M | −$288K | -0.2% | -0.01 | $1.3M | $1.2M | $67K | — | — |
| FY2020 · to Dec 31 | $102.1M | 56.8% | $221K | −$7.8M | -7.6% | -0.20 | $9.3M | $1.2M | $8.2M | — | — |
Every number comes from HARVARD BIOSCIENCE INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.